Atashkhoei 2012.

Trial name or title	Effect of oxytocin infusion on reducing operative blood loss during abdominal myomectomy
Methods	Randomised placebo controlled clinical trial
Participants	Inclusion criteria: Including criteria: Women undergoing abdominal myomectomy; over 35 years of age Excluding criteria: Patients candidate for hysteroscopic myomectomy; Patients with preoperative GnRH agonist consumption; Patients with history of cardiopulmonary disease
Interventions	Intervention 1: In the study group (n=40) oxytocin 30 u into 1000 ml normal saline will be infused during myomectomy. Intervention 2: In the placebo group (n=40) normal saline alone 1000 ml will be infused during myomectomy
Outcomes	Primary Outcome(s): The amount of bleeding. Timepoint: During myomectomy. Method of measurement: Count sponges and the amount of blood collected in the suction device ‐ according to ml Secondary Outcome(s): Hb and HcT values. Timepoint: Prior to operation and 24 h after operation. Method of measurement: Elyza method‐CBC ‐ Hb(g/dl), HcT(%) The amount of blood transfusion. Timepoint: Intra and postoperative. Method of measurement: Observation, Physical examination‐ Blood unit according to ml
Starting date	November 2012
Contact information	Dr Simin Atashkhoei, Al Zahra hospital, Artesh Jonoubi Ave, Tabriz, Iran
Notes